Back to Journals » Journal of Asthma and Allergy » Treatable Traits in Asthma and Upper Airway Disease
Journal of Asthma and Allergy
- View all (1096)
- Volume 19, 2026 (97)
- Volume 18, 2025 (148)
- Volume 17, 2024 (117)
- Volume 16, 2023 (125)
- Volume 15, 2022 (151)
- Volume 14, 2021 (149)
- Volume 13, 2020 (77)
- Volume 12, 2019 (37)
- Volume 11, 2018 (31)
- Volume 10, 2017 (36)
- Volume 9, 2016 (25)
- Volume 8, 2015 (14)
- Volume 7, 2014 (14)
- Volume 6, 2013 (16)
- Volume 5, 2012 (10)
- Volume 4, 2011 (11)
- Volume 3, 2010 (20)
- Volume 2, 2009 (12)
- Volume 1, 2008 (6)
Journal Articles:
- Targeted Personalized Biologic Therapies: Changing the Game in Asthma Treatment (2)
- Recurrent Pulmonary Infections: Diagnosis, Treatment, and Pathophysiology (1)
- Atopic Dermatitis and Other Atopic Comorbidities (5)
- Wheezing in Preschool Children: From Origins to Outcomes (1)
- From Guts to Lungs: Understanding Microbiome Dynamics in Respiratory Health (1)
- Artificial Intelligence and Machine Learning to Aid the Management of Allergic Respiratory Diseases (1)
- Anaphylaxis: Diagnosis and Treatment (5)
Treatable Traits in Asthma and Upper Airway Disease
The treatable traits approach offers a pragmatic framework to identify measurable and modifiable factors that contribute to exacerbations, corticosteroid burden, impaired quality of life, and variable treatment response in asthma. These traits may include airway inflammatory patterns, allergic sensitization, mucus hypersecretion, airflow limitation, and extra-bronchial comorbidities. Among these, upper airway diseases such as allergic rhinitis, chronic rhinosinusitis, and nasal polyposis are particularly relevant, reflecting the close anatomical, immunological, and clinical links between the upper and lower airways.